<div xmlns="http://www.w3.org/1999/xhtml"><title>antiretroviral_drug</title><table><thead><tr><th>id</th><th>term</th><th>name</th><th>url</th><th>wikidata</th><th>content</th><th>image</th><th>description</th><th>wikipedia</th></tr></thead><tbody><tr><td>drug allergy that has allergic trigger abacavir</td><td>Abacavir</td><td>‎abacavir allergy‎</td><td>https://en.wikipedia.orgAbacavir</td><td /><td /><td /><td /><td /></tr><tr><td>drug combination for HIV</td><td>Abacavir/dolutegravir/lamivudine</td><td>‎Abacavir/dolutegravir/lamivudine‎</td><td>https://en.wikipedia.orgAbacavir/dolutegravir/lamivudine</td><td /><td /><td /><td /><td /></tr><tr><td>combination drug for HIV</td><td>Abacavir/lamivudine</td><td>‎abacavir/lamivudine‎</td><td>https://en.wikipedia.orgAbacavir/lamivudine</td><td /><td /><td /><td /><td /></tr><tr><td>mixture of chemical compounds</td><td>Abacavir/lamivudine/zidovudine</td><td>‎Abacavir/lamivudine/zidovudine‎</td><td>https://en.wikipedia.orgAbacavir/lamivudine/zidovudine</td><td /><td /><td /><td /><td /></tr><tr><td></td><td>Abzyme</td><td></td><td>https://en.wikipedia.orgAbzyme</td><td /><td /><td /><td /><td /></tr><tr><td>chemical compound</td><td>Amdoxovir</td><td>‎amdoxovir‎</td><td>https://en.wikipedia.orgAmdoxovir</td><td /><td /><td /><td /><td /></tr><tr><td>scientific article</td><td>Amprenavir</td><td>‎Ritonavir increases plasma amprenavir (APV) exposure to a similar extent when coadministered with either fosamprenavir or APV.‎</td><td>https://en.wikipedia.orgAmprenavir</td><td /><td /><td /><td /><td /></tr><tr><td>pharmaceutical compound active against retroviruses</td><td>antiretroviral_drug</td><td>‎antiretroviral drug‎</td><td>https://en.wikipedia.organtiretroviral_drug</td><td /><td /><td /><td /><td /></tr><tr><td>Class of medications</td><td>Antiviral_drug</td><td>‎antiviral drug‎</td><td>https://en.wikipedia.orgAntiviral_drug</td><td /><td /><td /><td /><td /></tr><tr><td>chemical compound</td><td>Aplaviroc</td><td>‎aplaviroc‎</td><td>https://en.wikipedia.orgAplaviroc</td><td /><td /><td /><td /><td /></tr><tr><td>chemical compound</td><td>Apricitabine</td><td>‎apricitabine‎</td><td>https://en.wikipedia.orgApricitabine</td><td /><td /><td /><td /><td /></tr><tr><td>clinical trial</td><td>Atazanavir</td><td>‎Study of Boosted Atazanavir (ATV) Versus Non-boosted ATV in Naive Patients‎</td><td>https://en.wikipedia.orgAtazanavir</td><td /><td /><td /><td /><td /></tr><tr><td>pharmaceutical drug</td><td>Atazanavir/cobicistat</td><td>‎atazanavir / cobicistat‎</td><td>https://en.wikipedia.orgAtazanavir/cobicistat</td><td /><td /><td /><td /><td /></tr><tr><td>chemical compound</td><td>Atevirdine</td><td>‎atevirdine‎</td><td>https://en.wikipedia.orgAtevirdine</td><td /><td /><td /><td /><td /></tr><tr><td>chemical compound</td><td>Bevirimat</td><td>‎bevirimat‎</td><td>https://en.wikipedia.orgBevirimat</td><td /><td /><td /><td /><td /></tr><tr><td>chemical compound</td><td>BI_224436</td><td>‎BI 224436‎</td><td>https://en.wikipedia.orgBI_224436</td><td /><td /><td /><td /><td /></tr><tr><td>scientific article published on 4 October 2017</td><td>Bictegravir</td><td>‎Lack of Clinically Relevant Effect of Bictegravir (BIC, B) on Metformin (MET) Pharmacokinetics (PK) and Pharmacodynamics (PD).‎</td><td>https://en.wikipedia.orgBictegravir</td><td /><td /><td /><td /><td /></tr><tr><td>fixed dose combination drug</td><td>Bictegravir/emtricitabine/tenofovir_alafenamide</td><td>‎Bictegravir/emtricitabine/tenofovir alafenamide‎</td><td>https://en.wikipedia.orgBictegravir/emtricitabine/tenofovir_alafenamide</td><td /><td /><td /><td /><td /></tr><tr><td>chemical compound</td><td>BIT225</td><td>‎BIT225‎</td><td>https://en.wikipedia.orgBIT225</td><td /><td /><td /><td /><td /></tr><tr><td>clinical trial</td><td>BMS-955176</td><td>‎A Study to Evaluate the Effect of BMS-955176 on Pharmacokinetics of Dolutegravir and the Effect of Dolutegravir on the Pharmacokinetics of BMS-955176‎</td><td>https://en.wikipedia.orgBMS-955176</td><td /><td /><td /><td /><td /></tr><tr><td>clinical trial</td><td>Antiviral_drug#BNAbs.2F_BNAbs</td><td>‎Dual bNAb Treatment in Children‎</td><td>https://en.wikipedia.orgAntiviral_drug#BNAbs.2F_BNAbs</td><td /><td /><td /><td /><td /></tr><tr><td>chemical compound</td><td>Brecanavir</td><td>‎brecanavir‎</td><td>https://en.wikipedia.orgBrecanavir</td><td /><td /><td /><td /><td /></tr><tr><td>chemical compound</td><td>Cabotegravir</td><td>‎cabotegravir‎</td><td>https://en.wikipedia.orgCabotegravir</td><td /><td /><td /><td /><td /></tr><tr><td>chemical compound</td><td>Calanolide_A</td><td>‎calanolide a‎</td><td>https://en.wikipedia.orgCalanolide_A</td><td /><td /><td /><td /><td /></tr><tr><td>chemical compound</td><td>Capravirine</td><td>‎capravirine‎</td><td>https://en.wikipedia.orgCapravirine</td><td /><td /><td /><td /><td /></tr><tr><td>CM.antiretroviral_drug.25</td><td>Category:</td><td>Category:</td><td>https://en.wikipedia.orgCategory:</td><td /><td /><td /><td /><td /></tr><tr><td>CM.antiretroviral_drug.26</td><td>Category:Drug_templates_by_ATC</td><td>Category:Drug_templates_by_ATC</td><td>https://en.wikipedia.orgCategory:Drug_templates_by_ATC</td><td /><td /><td /><td /><td /></tr><tr><td>mammalian protein found in Homo sapiens</td><td>CCR5</td><td>‎C-C motif chemokine receptor 5 (gene/pseudogene)‎</td><td>https://en.wikipedia.orgCCR5</td><td /><td /><td /><td /><td /></tr><tr><td>mammalian protein found in Homo sapiens</td><td>CD4</td><td>‎CD4 molecule‎</td><td>https://en.wikipedia.orgCD4</td><td /><td /><td /><td /><td /></tr><tr><td>chemical compound</td><td>Cenicriviroc</td><td>‎cenicriviroc‎</td><td>https://en.wikipedia.orgCenicriviroc</td><td /><td /><td /><td /><td /></tr><tr><td>anti-HIV nucleoside-analog reverse transcriptase inhibitor</td><td>Censavudine</td><td>‎censavudine‎</td><td>https://en.wikipedia.orgCensavudine</td><td /><td /><td /><td /><td /></tr><tr><td></td><td>Ceragenin</td><td></td><td>https://en.wikipedia.orgCeragenin</td><td /><td /><td /><td /><td /></tr><tr><td>chemical compound</td><td>Cobicistat</td><td>‎cobicistat‎</td><td>https://en.wikipedia.orgCobicistat</td><td /><td /><td /><td /><td /></tr><tr><td>scientific article published on 01 November 1999</td><td>Fixed-dose_combination_(antiretroviral)</td><td>‎Quality assurance: protocol for assessing the rifampicin bioavailability of combined formulations in healthy volunteers‎</td><td>https://en.wikipedia.orgFixed-dose_combination_(antiretroviral)</td><td /><td /><td /><td /><td /></tr><tr><td>InterPro Domain</td><td>Cyanovirin-N</td><td>‎Cyanovirin-N domain‎</td><td>https://en.wikipedia.orgCyanovirin-N</td><td /><td /><td /><td /><td /></tr><tr><td>clinical trial</td><td>Darunavir</td><td>‎Study in HIV1-Positive, Virosuppressed Patients Currently inTreatment With Ritonavir-Boosted Protease Inhibitors (PI/r) Starting Cobicistat-Boosted Darunavir (DRV/c - Rezolsta)‎</td><td>https://en.wikipedia.orgDarunavir</td><td /><td /><td /><td /><td /></tr><tr><td>pharmaceutical drug</td><td>Darunavir/cobicistat</td><td>‎darunavir / cobicistat‎</td><td>https://en.wikipedia.orgDarunavir/cobicistat</td><td /><td /><td /><td /><td /></tr><tr><td></td><td>Darunavir/cobicistat/emtricitabine/tenofovir_alafenamide</td><td></td><td>https://en.wikipedia.orgDarunavir/cobicistat/emtricitabine/tenofovir_alafenamide</td><td /><td /><td /><td /><td /></tr><tr><td>clinical trial</td><td>Delavirdine</td><td>‎Virologic and Immunologic Activity of Continued Lamivudine (3TC) vs Delavirdine (DLV) in Combination With Indinavir (IDV) and Zidovudine (ZDV) or Stavudine (d4T) in 3TC-Experienced Subjects‎</td><td>https://en.wikipedia.orgDelavirdine</td><td /><td /><td /><td /><td /></tr><tr><td>chemical compound</td><td>Dexelvucitabine</td><td>‎dexelvucitabine‎</td><td>https://en.wikipedia.orgDexelvucitabine</td><td /><td /><td /><td /><td /></tr><tr><td>Wikimedia disambiguation page</td><td>United_States_Department_of_Health_and_Human_Services</td><td>‎DHHS‎</td><td>https://en.wikipedia.orgUnited_States_Department_of_Health_and_Human_Services</td><td /><td /><td /><td /><td /></tr><tr><td>class of chemical compounds</td><td>diarylpyrimidines</td><td>‎diarylpyrimidines‎</td><td>https://en.wikipedia.orgdiarylpyrimidines</td><td /><td /><td /><td /><td /></tr><tr><td>class of chemical compounds</td><td>Diarylpyrimidines</td><td>‎diarylpyrimidines‎</td><td>https://en.wikipedia.orgDiarylpyrimidines</td><td /><td /><td /><td /><td /></tr><tr><td>scientific article published on 01 June 1996</td><td>Didanosine</td><td>‎Development of resistance of zidovudine (ZDV) and didanosine (ddI) in HIV from patients in ZDV, ddI and alternating ZDV/ddI therapy‎</td><td>https://en.wikipedia.orgDidanosine</td><td /><td /><td /><td /><td /></tr><tr><td>journal</td><td>Discovery_and_development_of_CCR5_receptor_antagonists</td><td>‎Current Opinion in Drug Discovery and Development‎</td><td>https://en.wikipedia.orgDiscovery_and_development_of_CCR5_receptor_antagonists</td><td /><td /><td /><td /><td /></tr><tr><td>clinical trial</td><td>Dolutegravir</td><td>‎Study of Dolutegravir (DTG) on PK of Cenicriviroc (CVC), and CVC on PK of DTG &amp; on a Single Dose of Midazolam‎</td><td>https://en.wikipedia.orgDolutegravir</td><td /><td /><td /><td /><td /></tr><tr><td>drug combination for HIV</td><td>Dolutegravir/lamivudine</td><td>‎Abacavir/dolutegravir/lamivudine‎</td><td>https://en.wikipedia.orgDolutegravir/lamivudine</td><td /><td /><td /><td /><td /></tr><tr><td>chemical compound</td><td>Doravirine</td><td>‎doravirine‎</td><td>https://en.wikipedia.orgDoravirine</td><td /><td /><td /><td /><td /></tr><tr><td>combination drug</td><td>Doravirine/lamivudine/tenofovir_disoproxil</td><td>‎doravirine/lamivudine/tenofovir disoproxil fumarate‎</td><td>https://en.wikipedia.orgDoravirine/lamivudine/tenofovir_disoproxil</td><td /><td /><td /><td /><td /></tr><tr><td></td><td>Droxinavir</td><td></td><td>https://en.wikipedia.orgDroxinavir</td><td /><td /><td /><td /><td /></tr><tr><td>scientific article</td><td>Efavirenz</td><td>‎Pharmacokinetics of efavirenz (EFV) alone and in combination therapy with nelfinavir (NFV) in HIV-1 infected patients.‎</td><td>https://en.wikipedia.orgEfavirenz</td><td /><td /><td /><td /><td /></tr><tr><td>combination drug for HIV</td><td>Efavirenz/emtricitabine/tenofovir</td><td>‎Emtricitabine/tenofovir/efavirenz‎</td><td>https://en.wikipedia.orgEfavirenz/emtricitabine/tenofovir</td><td /><td /><td /><td /><td /></tr><tr><td></td><td>Elipovimab</td><td></td><td>https://en.wikipedia.orgElipovimab</td><td /><td /><td /><td /><td /></tr><tr><td>clinical trial</td><td>Elvitegravir</td><td>‎Elvitegravir (EVG) Cerebrospinal Fluid (CSF) Pharmacokinetics in HIV-Infected Individuals‎</td><td>https://en.wikipedia.orgElvitegravir</td><td /><td /><td /><td /><td /></tr><tr><td>pharmaceutical drug</td><td>Elvitegravir/cobicistat/emtricitabine/tenofovir</td><td>‎Elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil‎</td><td>https://en.wikipedia.orgElvitegravir/cobicistat/emtricitabine/tenofovir</td><td /><td /><td /><td /><td /></tr><tr><td>article</td><td>Elvitegravir/cobicistat/emtricitabine/tenofovir_alafenamide</td><td>‎Overdose of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in an HIV-1-infected subject with attempted suicide‎</td><td>https://en.wikipedia.orgElvitegravir/cobicistat/emtricitabine/tenofovir_alafenamide</td><td /><td /><td /><td /><td /></tr><tr><td>chemical compound</td><td>Elvucitabine</td><td>‎elvucitabine‎</td><td>https://en.wikipedia.orgElvucitabine</td><td /><td /><td /><td /><td /></tr><tr><td>chemical compound</td><td>Emivirine</td><td>‎emivirine‎</td><td>https://en.wikipedia.orgEmivirine</td><td /><td /><td /><td /><td /></tr><tr><td>scientific article</td><td>Emtricitabine</td><td>‎Randomized, double-blind study of emtricitabine (FTC) plus clevudine versus FTC alone in treatment of chronic hepatitis B.‎</td><td>https://en.wikipedia.orgEmtricitabine</td><td /><td /><td /><td /><td /></tr><tr><td>combination drug for HIV</td><td>Emtricitabine/rilpivirine/tenofovir</td><td>‎Emtricitabine/rilpivirine/tenofovir‎</td><td>https://en.wikipedia.orgEmtricitabine/rilpivirine/tenofovir</td><td /><td /><td /><td /><td /></tr><tr><td>pharmaceutical drug</td><td>Emtricitabine/rilpivirine/tenofovir_alafenamide</td><td>‎emtricitabine / rilpivirine / tenofovir alafenamide‎</td><td>https://en.wikipedia.orgEmtricitabine/rilpivirine/tenofovir_alafenamide</td><td /><td /><td /><td /><td /></tr><tr><td>drug combination for HIV prophylaxis</td><td>Emtricitabine/tenofovir</td><td>‎Tenofovir/emtricitabine‎</td><td>https://en.wikipedia.orgEmtricitabine/tenofovir</td><td /><td /><td /><td /><td /></tr><tr><td></td><td>Emtricitabine/tenofovir_alafenamide</td><td></td><td>https://en.wikipedia.orgEmtricitabine/tenofovir_alafenamide</td><td /><td /><td /><td /><td /></tr><tr><td>scientific article published on September 2008</td><td>Enfuvirtide</td><td>‎T20QoL: an observational multicenter cohort study to evaluate the quality of life in HIV-patients treated with enfuvirtide (ENF, T-20) in combination with an optimized background therapy.‎</td><td>https://en.wikipedia.orgEnfuvirtide</td><td /><td /><td /><td /><td /></tr><tr><td>scientific article</td><td>Entry_inhibitor</td><td>‎Progress in the identification of dengue virus entry/fusion inhibitors‎</td><td>https://en.wikipedia.orgEntry_inhibitor</td><td /><td /><td /><td /><td /></tr><tr><td>chemical compound</td><td>Epigallocatechin_gallate</td><td>‎epigallocatechin gallate‎</td><td>https://en.wikipedia.orgEpigallocatechin_gallate</td><td /><td /><td /><td /><td /></tr><tr><td>chemical compound</td><td>Etravirine</td><td>‎etravirine‎</td><td>https://en.wikipedia.orgEtravirine</td><td /><td /><td /><td /><td /></tr><tr><td>article</td><td>Fosamprenavir</td><td>‎Efficacy and safety of ritonavir-boosted fosamprenavir (FPV/r) in HIV-infected patients: 48-week results from an observational study‎</td><td>https://en.wikipedia.orgFosamprenavir</td><td /><td /><td /><td /><td /></tr><tr><td>chemical compound</td><td>Foscarnet</td><td>‎foscarnet‎</td><td>https://en.wikipedia.orgFoscarnet</td><td /><td /><td /><td /><td /></tr><tr><td>chemical compound</td><td>Fosdevirine</td><td>‎fosdevirine‎</td><td>https://en.wikipedia.orgFosdevirine</td><td /><td /><td /><td /><td /></tr><tr><td>chemical compound</td><td>Fostemsavir</td><td>‎fostemsavir‎</td><td>https://en.wikipedia.orgFostemsavir</td><td /><td /><td /><td /><td /></tr><tr><td>protein family</td><td>gp120</td><td>‎Envelope glycoprotein GP120‎</td><td>https://en.wikipedia.orggp120</td><td /><td /><td /><td /><td /></tr><tr><td></td><td>gp41</td><td></td><td>https://en.wikipedia.orggp41</td><td /><td /><td /><td /><td /></tr><tr><td></td><td>Griffithsin</td><td></td><td>https://en.wikipedia.orgGriffithsin</td><td /><td /><td /><td /><td /></tr><tr><td>human retrovirus, cause of AIDS</td><td>HIV</td><td>‎HIV‎</td><td>https://en.wikipedia.orgHIV</td><td /><td /><td /><td /><td /></tr><tr><td>chemical compound</td><td>Hydroxycarbamide</td><td>‎hydroxyurea‎</td><td>https://en.wikipedia.orgHydroxycarbamide</td><td /><td /><td /><td /><td /></tr><tr><td>chemical compound</td><td>Ibalizumab</td><td>‎Ibalizumab‎</td><td>https://en.wikipedia.orgIbalizumab</td><td /><td /><td /><td /><td /></tr><tr><td>scientific article</td><td>Indinavir</td><td>‎If taken 1 hour before indinavir (IDV), didanosine does not affect IDV exposure, despite persistent buffering effects.‎</td><td>https://en.wikipedia.orgIndinavir</td><td /><td /><td /><td /><td /></tr><tr><td>scientific article published on 27 December 2006</td><td>first-line_treatment</td><td>‎Options for a second-line antiretroviral regimen for HIV type 1-infected patients whose initial regimen of a fixed-dose combination of stavudine, lamivudine, and nevirapine fails‎</td><td>https://en.wikipedia.orgfirst-line_treatment</td><td /><td /><td /><td /><td /></tr><tr><td>Compounds which inhibit or antagonize biosynthesis or actions of integrase</td><td>Integrase_inhibitor</td><td>‎Integrase inhibitor‎</td><td>https://en.wikipedia.orgIntegrase_inhibitor</td><td /><td /><td /><td /><td /></tr><tr><td>chemical compound</td><td>Islatravir</td><td>‎islatravir‎</td><td>https://en.wikipedia.orgIslatravir</td><td /><td /><td /><td /><td /></tr><tr><td>Wikipedia disambiguation page</td><td>ATC_code_J05</td><td>‎J05‎</td><td>https://en.wikipedia.orgATC_code_J05</td><td /><td /><td /><td /><td /></tr><tr><td>chemical compound</td><td>KP-1461</td><td>‎KP-1461‎</td><td>https://en.wikipedia.orgKP-1461</td><td /><td /><td /><td /><td /></tr><tr><td>scientific article</td><td>Lamivudine</td><td>‎Lamivudine (3TC) resistance in HIV-1 reverse transcriptase involves steric hindrance with beta-branched amino acids‎</td><td>https://en.wikipedia.orgLamivudine</td><td /><td /><td /><td /><td /></tr><tr><td>pharmaceutical drug</td><td>Lamivudine/raltegravir</td><td>‎lamivudine / raltegravir‎</td><td>https://en.wikipedia.orgLamivudine/raltegravir</td><td /><td /><td /><td /><td /></tr><tr><td>mixture of chemical compounds</td><td>Lamivudine/zidovudine</td><td>‎Lamivudine/zidovudine‎</td><td>https://en.wikipedia.orgLamivudine/zidovudine</td><td /><td /><td /><td /><td /></tr><tr><td></td><td>Lasinavir</td><td></td><td>https://en.wikipedia.orgLasinavir</td><td /><td /><td /><td /><td /></tr><tr><td>chemical compound</td><td>Lersivirine</td><td>‎lersivirine‎</td><td>https://en.wikipedia.orgLersivirine</td><td /><td /><td /><td /><td /></tr><tr><td>chemical compound</td><td>Lodenosine</td><td>‎lodenosine‎</td><td>https://en.wikipedia.orgLodenosine</td><td /><td /><td /><td /><td /></tr><tr><td>clinical trial</td><td>Lopinavir</td><td>‎Lopinavir (LPV) Dose Reduction‎</td><td>https://en.wikipedia.orgLopinavir</td><td /><td /><td /><td /><td /></tr><tr><td>combination drug for HIV</td><td>Lopinavir/ritonavir</td><td>‎Lopinavir/ritonavir‎</td><td>https://en.wikipedia.orgLopinavir/ritonavir</td><td /><td /><td /><td /><td /></tr><tr><td>chemical compound</td><td>Loviride</td><td>‎loviride‎</td><td>https://en.wikipedia.orgLoviride</td><td /><td /><td /><td /><td /></tr><tr><td>scientific article published on 7 November 2011</td><td>Maraviroc</td><td>‎HIV-1 predisposed to acquiring resistance to maraviroc (MVC) and other CCR5 antagonists in vitro has an inherent, low-level ability to utilize MVC-bound CCR5 for entry‎</td><td>https://en.wikipedia.orgMaraviroc</td><td /><td /><td /><td /><td /></tr><tr><td></td><td>Maturation_inhibitor</td><td></td><td>https://en.wikipedia.orgMaturation_inhibitor</td><td /><td /><td /><td /><td /></tr><tr><td>phospholipid drug</td><td>Miltefosine</td><td>‎miltefosine‎</td><td>https://en.wikipedia.orgMiltefosine</td><td /><td /><td /><td /><td /></tr><tr><td>chemical compound</td><td>MK-2048</td><td>‎mk-2048‎</td><td>https://en.wikipedia.orgMK-2048</td><td /><td /><td /><td /><td /></tr><tr><td>chemical compound</td><td>Mozenavir</td><td>‎mozenavir‎</td><td>https://en.wikipedia.orgMozenavir</td><td /><td /><td /><td /><td /></tr><tr><td>scientific article</td><td>Nelfinavir</td><td>‎Isolation and molecular characterization of a nelfinavir (NFV)-resistant human immunodeficiency virus type 1 that exhibits NFV-dependent enhancement of replication.‎</td><td>https://en.wikipedia.orgNelfinavir</td><td /><td /><td /><td /><td /></tr><tr><td>scientific article</td><td>Nevirapine</td><td>‎Impact of nevirapine (NVP) plasma concentration on selection of resistant virus in mothers who received single-dose NVP to prevent perinatal human immunodeficiency virus type 1 transmission and persistence of resistant virus in their infected childr‎</td><td>https://en.wikipedia.orgNevirapine</td><td /><td /><td /><td /><td /></tr><tr><td>scientific article</td><td>Reverse-transcriptase_inhibitor#Non-nucleoside_reverse-transcriptase_inhibitors_(NNRTIs)</td><td>‎Non-nucleoside reverse transcriptase inhibitors: the NNRTI boom.‎</td><td>https://en.wikipedia.orgReverse-transcriptase_inhibitor#Non-nucleoside_reverse-transcriptase_inhibitors_(NNRTIs)</td><td /><td /><td /><td /><td /></tr><tr><td></td><td>Reverse-transcriptase_inhibitor#Nucleoside_analog_reverse-transcriptase_inhibitors_.28NARTIs_or_NRTIs.29</td><td></td><td>https://en.wikipedia.orgReverse-transcriptase_inhibitor#Nucleoside_analog_reverse-transcriptase_inhibitors_.28NARTIs_or_NRTIs.29</td><td /><td /><td /><td /><td /></tr><tr><td>clinical trial</td><td>Reverse-transcriptase_inhibitor#Nucleotide_analog_reverse-transcriptase_inhibitors_.28NtARTIs_or_NtRTIs.29</td><td>‎A Pilot Study of Triple NtRTI/NsRTI Therapy in Antiretroviral Naive HIV-1 Infected Patients‎</td><td>https://en.wikipedia.orgReverse-transcriptase_inhibitor#Nucleotide_analog_reverse-transcriptase_inhibitors_.28NtARTIs_or_NtRTIs.29</td><td /><td /><td /><td /><td /></tr><tr><td>Any cellular metabolic process involving nucleobases, nucleosides, nucleotides and nucleic acids.</td><td>Reverse-transcriptase_inhibitor</td><td>‎nucleobase-containing compound metabolic process‎</td><td>https://en.wikipedia.orgReverse-transcriptase_inhibitor</td><td /><td /><td /><td /><td /></tr><tr><td></td><td>Nucleoside_analogue</td><td></td><td>https://en.wikipedia.orgNucleoside_analogue</td><td /><td /><td /><td /><td /></tr><tr><td>scientific article</td><td>Nucleotide_analogue</td><td>‎Mutational patterns in the HIV genome and cross-resistance following nucleoside and nucleotide analogue drug exposure.‎</td><td>https://en.wikipedia.orgNucleotide_analogue</td><td /><td /><td /><td /><td /></tr><tr><td>chemical compound</td><td>Palinavir</td><td>‎palinavir‎</td><td>https://en.wikipedia.orgPalinavir</td><td /><td /><td /><td /><td /></tr><tr><td></td><td>Portmanteau_inhibitor</td><td></td><td>https://en.wikipedia.orgPortmanteau_inhibitor</td><td /><td /><td /><td /><td /></tr><tr><td>monoclonal antibody against CCR5, for prevention of fusion of HIV with CCR5+ cells</td><td>PRO_140</td><td>‎PRO 140‎</td><td>https://en.wikipedia.orgPRO_140</td><td /><td /><td /><td /><td /></tr><tr><td>scientific article</td><td>Protease_inhibitor_(pharmacology)</td><td>‎Why switch from protease inhibitors (PI) to non-nucleoside reverse transcriptase inhibitors (NNRTI)?‎</td><td>https://en.wikipedia.orgProtease_inhibitor_(pharmacology)</td><td /><td /><td /><td /><td /></tr><tr><td>clinical trial</td><td>Racivir</td><td>‎A 14-Day Study of Racivir When Used in Combination in HIV-Infected Males‎</td><td>https://en.wikipedia.orgRacivir</td><td /><td /><td /><td /><td /></tr><tr><td>scientific article published on 01 January 2007</td><td>Raltegravir</td><td>‎Expanded access drug profile: raltegravir (RAL, MK-0518)‎</td><td>https://en.wikipedia.orgRaltegravir</td><td /><td /><td /><td /><td /></tr><tr><td>class of enzymes</td><td>Reverse-transcriptase_inhibitor</td><td>‎reverse transcriptase‎</td><td>https://en.wikipedia.orgReverse-transcriptase_inhibitor</td><td /><td /><td /><td /><td /></tr><tr><td>scientific article published on 17 October 2011</td><td>Rilpivirine</td><td>‎Long-term efficacy, safety, and tolerability of rilpivirine (RPV, TMC278) in HIV type 1-infected antiretroviral-naive patients: week 192 results from a phase IIb randomized trial.‎</td><td>https://en.wikipedia.orgRilpivirine</td><td /><td /><td /><td /><td /></tr><tr><td>clinical trial</td><td>Ritonavir</td><td>‎Real World Evidence of the Effectiveness of Paritaprevir/Ritonavir (r) - Ombitasvir, + Dasabuvir Without Ribavirin in Participants With Chronic Hepatitis C and Compensated Liver Cirrhosis in the Russian Federation‎</td><td>https://en.wikipedia.orgRitonavir</td><td /><td /><td /><td /><td /></tr><tr><td>clinical trial</td><td>Ritonavir</td><td>‎A Phase 2 Study to Evaluate Pharmacokinetics, Safety and Efficacy of TMC114/Ritonavir (Rtv) in Human Immunodeficiency Virus (HIV)-1 Infected Children and Adolescents‎</td><td>https://en.wikipedia.orgRitonavir</td><td /><td /><td /><td /><td /></tr><tr><td>chemical compound</td><td>Saquinavir</td><td>‎saquinavir‎</td><td>https://en.wikipedia.orgSaquinavir</td><td /><td /><td /><td /><td /></tr><tr><td></td><td>Scytovirin</td><td></td><td>https://en.wikipedia.orgScytovirin</td><td /><td /><td /><td /><td /></tr><tr><td>chemical compound</td><td>Seliciclib</td><td>‎seliciclib‎</td><td>https://en.wikipedia.orgSeliciclib</td><td /><td /><td /><td /><td /></tr><tr><td>chemical compound</td><td>Stampidine</td><td>‎Stampidine‎</td><td>https://en.wikipedia.orgStampidine</td><td /><td /><td /><td /><td /></tr><tr><td>clinical trial</td><td>Stavudine</td><td>‎A Randomized, Comparative Trial of Zidovudine (AZT) Versus 2',3'-Didehydro-3'-Deoxythymidine (Stavudine; d4T) in Children With HIV Infection‎</td><td>https://en.wikipedia.orgStavudine</td><td /><td /><td /><td /><td /></tr><tr><td></td><td>Synergistic_enhancer_(antiretroviral)</td><td></td><td>https://en.wikipedia.orgSynergistic_enhancer_(antiretroviral)</td><td /><td /><td /><td /><td /></tr><tr><td>scientific article</td><td>Tat_(HIV)#Clinical_significance</td><td>‎Inhibition of HIV replication in acute and chronic infections in vitro by a Tat antagonist‎</td><td>https://en.wikipedia.orgTat_(HIV)#Clinical_significance</td><td /><td /><td /><td /><td /></tr><tr><td>chemical compound</td><td>Telinavir</td><td>‎telinavir‎</td><td>https://en.wikipedia.orgTelinavir</td><td /><td /><td /><td /><td /></tr><tr><td>scientific article published on 17 January 2018</td><td>Tenofovir_alafenamide</td><td>‎Tenofovir alafenamide (TAF) treatment of HBV, what are the unanswered questions?‎</td><td>https://en.wikipedia.orgTenofovir_alafenamide</td><td /><td /><td /><td /><td /></tr><tr><td>antiretroviral drug, used to treat or prevent HIV and hepatitis infections</td><td>Tenofovir_disoproxil</td><td>‎tenofovir‎</td><td>https://en.wikipedia.orgTenofovir_disoproxil</td><td /><td /><td /><td /><td /></tr><tr><td>scientific article</td><td>Tipranavir</td><td>‎Tipranavir (TPV) genotypic inhibitory quotient predicts virological response at 48 weeks to TPV-based salvage regimens.‎</td><td>https://en.wikipedia.orgTipranavir</td><td /><td /><td /><td /><td /></tr><tr><td>scientific article</td><td>Transcription_(genetics)</td><td>‎ATF-a0, a novel variant of the ATF/CREB transcription factor family, forms a dominant transcription inhibitor in ATF-a heterodimers‎</td><td>https://en.wikipedia.orgTranscription_(genetics)</td><td /><td /><td /><td /><td /></tr><tr><td>microbial protein found in Clostridioides difficile 630</td><td>Antiviral_drug#Translation_.2F_ribozymes</td><td>‎Translation inhibitor endoribonuclease CD630_25130‎</td><td>https://en.wikipedia.orgAntiviral_drug#Translation_.2F_ribozymes</td><td /><td /><td /><td /><td /></tr><tr><td></td><td>Tre_recombinase</td><td></td><td>https://en.wikipedia.orgTre_recombinase</td><td /><td /><td /><td /><td /></tr><tr><td></td><td>Trichosanthin</td><td></td><td>https://en.wikipedia.orgTrichosanthin</td><td /><td /><td /><td /><td /></tr><tr><td>scientific article</td><td>TRIM5alpha</td><td>‎TRIM5alpha selectively binds a restriction-sensitive retroviral capsid‎</td><td>https://en.wikipedia.orgTRIM5alpha</td><td /><td /><td /><td /><td /></tr><tr><td>experimental antibody for HIV treatment</td><td>UB421</td><td>‎UB-421‎</td><td>https://en.wikipedia.orgUB421</td><td /><td /><td /><td /><td /></tr><tr><td>scientific article published on September 1995</td><td>Antiviral_drug#Uncoating_inhibitor</td><td>‎Infectious cDNA clones of echovirus 12 and a variant resistant against the uncoating inhibitor rhodanine differ in seven amino acids.‎</td><td>https://en.wikipedia.orgAntiviral_drug#Uncoating_inhibitor</td><td /><td /><td /><td /><td /></tr><tr><td>chemical compound</td><td>Vicriviroc</td><td>‎vicriviroc‎</td><td>https://en.wikipedia.orgVicriviroc</td><td /><td /><td /><td /><td /></tr><tr><td>scientific article</td><td>Zalcitabine</td><td>‎Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults.‎</td><td>https://en.wikipedia.orgZalcitabine</td><td /><td /><td /><td /><td /></tr><tr><td>chemical compound</td><td>Zidovudine</td><td>‎zidovudine‎</td><td>https://en.wikipedia.orgZidovudine</td><td /><td /><td /><td /><td /></tr><tr><td>scientific article</td><td>Zinc_finger_protein_transcription_factor</td><td>‎Cloning and characterization of a gene encoding novel zinc finger protein transcription factor induced under water deficit stress from rice (Oryza sativa) cv. N-22.‎</td><td>https://en.wikipedia.orgZinc_finger_protein_transcription_factor</td><td /><td /><td /><td /><td /></tr></tbody></table></div>